Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Clinical trial NCT01049984 · COMPLETED
Trial details
- NCT number
- NCT01049984
- Sponsor
- Teva Neuroscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-10-01
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.